ID: ALA174669

Max Phase: Preclinical

Molecular Formula: C10H22N2O

Molecular Weight: 186.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)NCCCCCCCCN

Standard InChI:  InChI=1S/C10H22N2O/c1-10(13)12-9-7-5-3-2-4-6-8-11/h2-9,11H2,1H3,(H,12,13)

Standard InChI Key:  GWPUBAZPNRZCKG-UHFFFAOYSA-N

Associated Targets(Human)

Polyamine oxidase 84 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 186.30Molecular Weight (Monoisotopic): 186.1732AlogP: 1.42#Rotatable Bonds: 8
Polar Surface Area: 55.12Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.21CX LogP: 0.75CX LogD: -1.85
Aromatic Rings: 0Heavy Atoms: 13QED Weighted: 0.56Np Likeness Score: -0.09

References

1. Dredar SA, Blankenship JW, Marchant PE, Manneh V, Fries DS..  (1989)  Design and synthesis of inhibitors of N8-acetylspermidine deacetylase.,  32  (5): [PMID:2709384] [10.1021/jm00125a010]

Source